Abstract

General Guideline

Abstract Submission Guideline

The abstract submission will be divided into 3 categories:

A. Case Report

B. Original article

C. Literature review

1) STRUCTURE
• Title: Maximum of 120 characters (including space).
• Author: The number of authors is not limited.
– Contents Case report consists of background, case illustration, discussion, conclusion, and references.
– Original article and literature review consist of background, objective, method, result, discussion, conclusion, and references.
• Word count: Maximum of 250 words (for the whole abstract).
• Language: English

2) SUBMISSION GUIDELINE
• All abstracts must be submitted in English exclusively via the online abstract submission system.
• AUTHORS – FIRST (PRESENTING) AUTHOR – The first author will be the presenting author. The first (presenting) author is expected to register and pay the full registration fee, attend the Congress and make the presentation.
• Please provide an accurate email address and handphone number for the first (presenting) author. Abstract submission results and abstract-related correspondence will be sent by email to the first author.
• Authors can submit a maximum of 5 abstracts and they can serve as the first author of 3 submitted abstracts at most. Among the 3 abstracts, they can present a maximum of 2 abstracts that are of the same presentation type.
• CO-AUTHOR(S) – A maximum of five co-authors are allowed for each abstract. Type in the names and affiliations as you would like them to appear in any publications. Please give the names in full for each of the co-authors. Initials are only accepted for middle names if any.
• The ABSTRACT TITLE must be concise. Avoid using abbreviations in the title.
• Abstract content for ORIGINAL ARTICLE and LITERATURE REVIEW (excluding title, authors, highest degrees and institutions) should include the following headings: INTRODUCTION, METHODS, RESULTS, DISCUSSION and CONCLUSION. The abstract must not exceed 250 words. Do not include graphs, tables, images or references in the abstract.
• Abstract content for CASE REPORT (excluding title, authors, highest degrees and institutions) should include the following headings: INTRODUCTION, CASE REPORT, DISCUSSION and CONCLUSION. The abstract must not exceed 250 words. Do not include graphs, tables,
images or references in the abstract.
• Please define each abbreviation the first time it is used in the abstract by placing what it stands for in parentheses.
• It is the author’s responsibility to submit an abstract with correct spelling and grammar. The Selection Committee, however, reserves the right to edit the abstract if it has significant spelling and grammatical mistakes.

• All successfully submitted abstracts will be acknowledged with an electronic receipt with an abstract reference number, which should be quoted in all future correspondence.
• The Selection Committee strongly recommends that authors submit their abstracts as early
as possible to avoid a last-minute rush and system congestion. Kindly note that only the latest version will be reviewed.
• Late submissions will NOT be considered.
• Submitted abstracts will be peer-reviewed by the Selection Committee. The review process is confidential and the decision is final.
• Authors may be given the option to change the format of their presentation as a condition for acceptance.
• The 14th National Endocrinology Forum holds the copyright to all the materials presented at the Congress and may reproduce the materials in any form for distribution.

3) FREE PAPERS
• Please select the right category for the abstract.
• Free paper submissions include an oral presentation. Any accepted authors will need to
present a talk of 8 (eight) minutes for the presentation, with an additional 2 (two) minutes for
questions and answers with the judges and the audience
• Presentation materials should be in ppt or pptx format
• If ‘Free Paper’ is selected to be the first preference, and the secondary preference ‘E-Poster’ is
chosen, authors will have the opportunity to have the abstract reviewed for e-poster
presentation in the event that it is not accepted for free paper presentation.

4) CHECKLIST
• Before submission, please check:
• If the abstract has a concise, descriptive title;
• If the study has sufficient data leading to conclusive outcomes;
• If the abstract states clearly the purpose, methods, results and conclusions of the study;
• If the study is conducted in a methodologically correct way;
• If the abstract is proofread and/or edited by a native speaker of English;
• If the abstract is within the word limit;
• If financial disclosures for each of the authors are made.